Nicholas Prairie

Proskauer Rose LLP

Contact
View Bio
RSS

Latest Posts › Abbreviated New Drug Application (ANDA)

Share:

Novo Nordisk v. Mylan: Method of Treatment Claims Must Be Aligned with Label

Method-of-treatment (“MoT”) claims can be powerful tools for pharmaceutical companies seeking to extend market exclusivity for their products after the original composition-of-matter patents expire. However, the District of...more

9/8/2025  /  Abbreviated New Drug Application (ANDA) , Food and Drug Administration (FDA) , Hatch-Waxman , Induced Infringement , Method Claims , Patent Infringement , Patent Litigation , Pharmaceutical Industry , Pharmaceutical Patents , Prosecution History Estoppel
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide